MassBio Investors Forum focuses on opportunities for partnering around the globe

October 6, 2009

 

More than 400 meet to address challenge of capital formation

 Both nascent and seasoned companies presented their innovative ideas on cutting edge therapies at the 11th annual MassBio Investors Forum held in Boston today, providing to potential investors and partners a look into the research being down both in Massachusetts and abroad.

 The MassBio Investors Forum is New England's largest biotechnology investment meeting, with attendance from biotech and pharmaceutical companies, venture capital firms, investment banks, government agencies and disease foundations. This year, the meeting expanded to include participation by companies from around the globe in partnership with MassBio foreign agency members. Representatives from companies located in 12 different countries attended the Forum. More than 500 people attended overall.

 "Biotechnology is truly a global industry," Coughlin said. "We are proud that this Investors Forum has become a destination for some of the great organizations and thought leaders from other biotech clusters around the world."

 In that spirit of global partnership, MassBio signed its first-ever Memorandum of Understanding (MOU) with the United Kingdom's Golden Triangle Partnership. The MOU outlines the two organization's commitment to facilitate cross-ocean investment and partnering. The Golden Triangle is composed of the UK's three primary life sciences clusters of Oxford, London and Cambridge.

 Commenting on the historic event, Oxford Bioscience Network CEO Jon Rees said, "The UK is recognized around for the world for its life sciences discovery and innovation. But in today's economy we all know the key to fast-track development and commercialization is partnering and collaboration. This MOU is a critical first step in creating dialogues with like-minded Massachusetts companies."

 The MOU signing capped off a day filled with industry-focused panels and keynote presentations, including sessions on the biotech business model and structuring strategic alliances. Keynote speakers included Steve Burrill, CEO of Burrill & Company, Gary Pisano, Harry E. Figgie, Jr. Professor of Business Administration at Harvard Business School, and Massachusetts Lieutenant Governor Timothy Murray.

 The MassBio Investors Forum also featured presentations by 28 public and private companies seeking to raise funds or identify potential development partners.

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Upcoming Events email!
For Email Marketing you can trust

MassBio